The Palantir NHS contract raises urgent questions about data privacy and public trust in Britain. Our investigation into the US defence tech giant's foothold in the British state reveals troubling findings that demand immediate attention from policymakers like Andy Burnham.
What Is the Palantir Federated Data Platform?
The Federated Data Platform (FDP), built on Palantir's Foundry software, was sold as a revolutionary tool to integrate NHS data across hospitals, pharmacies, and clinics. NHS England claims it has rolled out to nearly two-thirds of its target sites since 2024. However, our year-long investigation, published in the London Review of Books, uncovers serious efficacy concerns.
Key Findings From Our Investigation
- Whistleblower accounts from NHS staff reveal operational failures and data integration issues.
- Confidential documents show cost overruns and unmet performance benchmarks.
- Lobbying efforts by Palantir executives bypassed standard procurement transparency.
Palantir vs. NHS Values: A Comparison
| Factor | Palantir FDP | UK Public Sector Expectations |
|---|---|---|
| Data Privacy | Shares data with US parent company | Strict GDPR and NHS confidentiality |
| Cost | £330m contract | Value-for-money taxpayer oversight |
| Performance | Unverified internal metrics | Independent audit required |
Why This Matters for British Democracy
The science, innovation and technology committee has already warned of a clear mismatch with UK values. Critics, including former Conservative adviser Camilla Cavendish, argue that what matters is what works—but our data suggests Palantir's technology does not work as promised.
FAQ
What is Palantir's role in the NHS?
Palantir provides the Federated Data Platform, a software system meant to unify NHS patient data across England. The £330m contract was awarded in 2023.
Why is Palantir controversial?
Palantir has ties to US defence and surveillance agencies, raising concerns about patient data privacy and sovereignty. Whistleblowers have also reported operational failures.
Should the UK government cancel the Palantir contract?
Many MPs and experts argue the contract should be reviewed or terminated due to mismanagement, cost, and ethical concerns. The decision rests with incoming leaders like Andy Burnham.
Our investigation concludes that Palantir's foothold in Britain is a cautionary tale about unchecked corporate influence in public services. The new government must prioritize transparency and patient trust over Silicon Valley promises.